These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1632847)

  • 1. The oxidative modification of low density lipoprotein by human lymphocytes.
    Lamb DJ; Wilkins GM; Leake DS
    Atherosclerosis; 1992 Feb; 92(2-3):187-92. PubMed ID: 1632847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.
    Wieland E; Brandes A; Armstrong VW; Oellerich M
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):725-31. PubMed ID: 8305616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells.
    Itabe H; Takano T
    J Atheroscler Thromb; 2000; 7(3):123-31. PubMed ID: 11480452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.
    Hoff HF; O'Neil J
    Atherosclerosis; 1988 Mar; 70(1-2):29-41. PubMed ID: 3355615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of oxidized LDL by macrophages.
    Jessup W; Kritharides L
    Curr Opin Lipidol; 2000 Oct; 11(5):473-81. PubMed ID: 11048890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway.
    Katsura M; Forster LA; Ferns GA; Anggård EE
    Biochim Biophys Acta; 1994 Jul; 1213(2):231-7. PubMed ID: 8025135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
    Frei B
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.
    Parthasarathy S; Printz DJ; Boyd D; Joy L; Steinberg D
    Arteriosclerosis; 1986; 6(5):505-10. PubMed ID: 3767695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S
    Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of low density lipoprotein by bovine and porcine aortic endothelial cells and porcine endocardial cells in culture.
    Morgan J; Smith JA; Wilkins GM; Leake DS
    Atherosclerosis; 1993 Sep; 102(2):209-16. PubMed ID: 8251007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.
    Lamb DJ; Mitchinson MJ; Leake DS
    FEBS Lett; 1995 Oct; 374(1):12-6. PubMed ID: 7589497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage foam cells from human aortic fatty streaks take up beta-VLDL and acetylated LDL in primary culture.
    Jaakkola O; Ylä-Herttuala S; Särkioja T; Nikkari T
    Atherosclerosis; 1989 Oct; 79(2-3):173-82. PubMed ID: 2688664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
    Yuan XM; Anders WL; Olsson AG; Brunk UT
    Atherosclerosis; 1996 Jul; 124(1):61-73. PubMed ID: 8800494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation and its role in atherosclerosis.
    Esterbauer H; Wäg G; Puhl H
    Br Med Bull; 1993 Jul; 49(3):566-76. PubMed ID: 8221023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid can either increase or decrease low density lipoprotein modification.
    Stait SE; Leake DS
    FEBS Lett; 1994 Mar; 341(2-3):263-7. PubMed ID: 8137950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of macrophage foam cell formation by Chlamydia pneumoniae.
    Kalayoglu MV; Byrne GI
    J Infect Dis; 1998 Mar; 177(3):725-9. PubMed ID: 9498454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.